. 2021 Apr 15;12:657985. doi: 10.3389/fphar.2021.657985

TABLE 1.

Sample characteristics and associations with prior use of PGx tests.

	Total		Ever used pharmacogenetic tests				p-value
	Total		No N = 103 (83.7%)		Yes N = 20 (16.3%)
	N	%	N	%	N	%
Metropolitan region**	92	74.8	79	70.9	19	95.0	0.02
Practice at (% yes) ^a
Public system**	67	54.5	61	59.2	6	30	0.02
University or research center	27	22	21	20.4	6	30	0.34
Private medical center*	90	73.2	72	69.9	18	90	0.06
Nonprofit foundation	5	4.1	4	3.9	1	5	0.81
In training	3	2.4	3	2.9	0	0	0.44
Other	16	13	13	12.6	3	15	0.77
Clinical practice (% yes) ^a
Child psychiatry	19	15.4	15	14.6	4	20	0.53
Adolescent psychiatry	31	25.2	25	24.3	6	30	0.59
Adult psychiatry	104	84.6	87	84.5	17	85	0.95
Years in practice**
0 to 10	56	45.5	51	49.5	5	25
11 to 20	26	21.1	22	21.4	4	20
21 to 30	22	17.9	19	18.4	3	15	0.02
31 to 40	16	13	9	8.7	7	35
41 or more	3	2.4	2	1.9	1	5
Participated in research in past 5 years
Yes	75	61	62	60.2	13	65	0.68

Note: N = 123. ***p < 0.01, **p < 0.05, *p < 0.1.

^{^a}